Quantcast

Latest Lectins Stories

2014-07-30 12:31:04

WAYNE, Pa., July 30, 2014 /PRNewswire/ -- Ryan & Maniskas, LLP has commenced an investigation into potential securities law violations by certain officers of Galectin Therapeutics, Inc. ("Galectin" or the "Company") (NASDAQ: GALT). http://photos.prnewswire.com/prnvar/20121112/MM11729LOGO Galectin shareholders who purchased Galectin shares should contact Richard A. Maniskas, Esquire at 877-316-3218 or at rmaniskas@rmclasslaw.com to learn more about this investigation or visit:...

2014-07-30 12:30:06

NEW YORK, July 30, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Galectin Therapeutics, Inc. ("Galectin Therapeutics" or the "Company") (NasdaqCM: GALT). Such investors are advised to contact Edward N. Gewirtz or his investor relation's coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484. The investigation focuses on whether the Company and certain of its...

2014-03-04 08:31:20

-- Successful Phase 1 Results Set the Stage for Trials in Patients with Life-Threatening Blood Disorders -- SEATTLE, March 4, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an investigational new drug (IND) application to initiate the Phase 2 clinical program for OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin?associated serine protease-2 (MASP-2), the...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related